Roche Vice Chairman Hoffmann Discusses China Strategy

The transcript discusses the pharmaceutical opportunities in China, focusing on cancer treatment and the growing market. It highlights the impact of deregulation, competition, and the introduction of new technologies. The company aims to expand its market share by leveraging universal health coverage and addressing local needs. Pricing strategies are discussed, emphasizing negotiation over immediate returns. The transcript also touches on trade agreements and the potential for future industry growth, particularly in cancer research and treatment.

How does the text describe the competition among China's drug makers?

What challenges does the speaker mention regarding pricing in the pharmaceutical industry?

What future plans does the company have for introducing new drugs in China?